Lattm1(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Lattm1(EUCOMM)Wtsi |
| Name: |
linker for activation of T cells; targeted mutation 1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4881071 |
| Gene: |
Lat Location: Chr7:125962996-125968742 bp, - strand Genetic Position: Chr7, 69.01 cM
|
| IMPC: |
Lat gene page |
|
| Mutant Cell Lines: |
EPD0711_1_A05, EPD0711_1_B05, EPD0711_1_B06, EPD0711_1_B07, EPD0711_1_C06, EPD0711_1_C07, EPD0711_1_E05, EPD0711_1_E06, EPD0711_1_E07, EPD0711_1_E08, EPD0711_1_F06, EPD0711_1_H05, EPD0711_1_H06, EPD0711_1_H07, EPD0711_1_H08 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
EUCOMM
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 4848 starting at position 125963300 and ending at position 125968148 of Chromosome 7 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:155845, J:173534)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Lat Mutation: |
11 strains or lines available
|
|
| Original: |
J:155845 Wellcome Trust Sanger Institute, Alleles produced for the EUCOMM and EUCOMMTools projects by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2010; |
| All: |
2 reference(s) |
|